Get started
Author

Penglin Pan

ORCID: 0000-0002-0922-5631
Observed ORCID: 0000-0002-0922-5631
OpenAlex ID: A5021158665
HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer
2022 · Yingke Zhou, Xin Jin, et al. · Theranostics · 80
PDF
HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer
2022 · Penglin Pan, Gengdu Qin, et al. · Cancer Research · 27
TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaks
2023 · Jian Ma, Yingke Zhou, et al. · Nature Communications · 25
PDF
ITGA2 overexpression inhibits DNA repair and confers sensitivity to radiotherapies in pancreatic cancer
2022 · Chen Zhou, Shoukang Li, et al. · Cancer Letters · 16
PDF
Safety and Efficacy of Irreversible Electroporation in Locally Advanced Pancreatic Cancer: An Evaluation from a Surgeon’s Perspective
2022 · Jian Shen, Penglin Pan, et al. · Cancers · 7
PDF
RNF43 deficiency activates YBX1-MYC-driven oxidative phosphorylation in pancreatic cancer
2026 · Gengdu Qin, Penglin Pan, et al. · Cancer Letters
Supplementary Data from HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer
2025 · Penglin Pan, Gengdu Qin, et al.
Supplementary table S5 from HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer
2025 · Penglin Pan, Gengdu Qin, et al.
Data from HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer
2023 · Penglin Pan, Gengdu Qin, et al.
Data from HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer
2023 · Penglin Pan, Gengdu Qin, et al.
Supplementary Data from HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer
2023 · Penglin Pan, Gengdu Qin, et al.
Supplementary table S5 from HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer
2023 · Penglin Pan, Gengdu Qin, et al.
Supplementary table S5 from HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer
2023 · Penglin Pan, Gengdu Qin, et al.
Supplementary Data from HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer
2023 · Penglin Pan, Gengdu Qin, et al.
Works count: 14
Citation count: 155
H-index: 5
I10-index: 4
Year
Topic
Type